Cargando…
PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2
Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we s...
Autores principales: | Wang, Wei, Gu, Fang, Wei, Cai, Tang, Yigui, Zheng, Xin, Ren, Mingqiang, Qin, Yide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622516/ https://www.ncbi.nlm.nih.gov/pubmed/23593287 http://dx.doi.org/10.1371/journal.pone.0060701 |
Ejemplares similares
-
Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress
por: Qi, Nan, et al.
Publicado: (2017) -
Milk-derived hexapeptide PGPIPN prevents and attenuates acute alcoholic liver injury in mice by reducing endoplasmic reticulum stress
por: Xu, Qia, et al.
Publicado: (2020) -
The milk-derived fusion peptide, ACFP, suppresses the growth of primary human ovarian cancer cells by regulating apoptotic gene expression and signaling pathways
por: Zhou, Juan, et al.
Publicado: (2016) -
Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway
por: Guo, Ruowen, et al.
Publicado: (2021) -
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease
por: Kurnellas, Michael P., et al.
Publicado: (2014)